Search results for: 'Biological Data Management'

01 Apr 2019  |  North America  |  Market Research

Global Enterprise Content Management Market for Healthcare, Forecast to 2023

Healthcare Digitisation, Paperless Drive in Hospitals, and Need for Information Governance Will Yield New Growth Opportunities for Healthcare Content Management Solutions

Infographics

×

Key Issues Addressed

For over two decades, healthcare systems across the globe have considered digitisation a priority and have invested heavily in eHealth systems. This has resulted in the extensive proliferation of several clinical and non-clinical information systems in healthcare organizations. These information systems are capable of handling structured content ge...

To deliver a great customer experience, organizations today want a single view of customers across all touchpoints, which can be achieved through customer relationship management (CRM) solutions. The goal for businesses is to capture and leverage the wealth of available customer data to have profitable, productive, value-rich, experience-enhancing,...

06 Oct 2021  |  North America  |  Market Research

US Chronic Disease Management Growth Opportunities

Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management

Infographics

×

Key Issues Addressed

The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...

As the number of aging, technologically obsolete imaging systems at medical facilities increases the need to shift to new imaging equipment with advanced technology, hospitals and imaging centers especially in developing economies seek MES models that provide a viable long-term equipment procurement strategy. MES offers technical infrastructure sup...

Businesses want customer relationship management (CRM) software that unifies all data related to customers and deals, and provides advanced integrations with business applications and advanced security. The CRM industry is in the growth phase, with solution providers consolidating. Some providers offer combined CRM suites while others offer sta...

Healthcare challenges such as workforce shortages, decline in revenue and operating margins, patient payment collection issues, complex claims compliance requirements, and increased patient expectations for seamless experience are compelling healthcare providers to rethink their revenue cycle management (RCM) approach. Providers are realizing the i...

Database-as-a-Service (DBaaS) is a cloud-based approach to the management and storage of data. By placing the database software and associated management functions in the cloud, DBaaS enables databases to scale elastically on-demand. It also removes the management of the database software—such as updates, patches, or security measures—from the ente...

Frost & Sullivan discusses the real benefits provided by customer experience management (CXM) solutions, illustrating the 9 hottest trends characterising the CXM space in 2015 and offering advice to end users and vendors on how to procure and promote CXM solutions. Vendors claiming to offer CXM solutions cluster into 1 of 5 groups depending on the ...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...